The AD-RIDDLE project invites healthcare professionals involved in Alzheimer’s care or diagnosis to participate in a short online survey exploring their experiences with emerging diagnostic tools.
AD-RIDDLE is a public-private partnership bringing together academic, industry and philanthropic partners to advance the prevention, detection and treatment of Alzheimer’s disease (AD). The project is developing and testing a modular “toolbox platform” designed to reduce barriers to timely detection and treatment, and ultimately accelerate innovation in AD care.
As part of the project, an implementation evaluation study examines the real-world integration of new diagnostic tools for AD across primary and specialised care settings in several European health systems. The study explores factors influencing their adoption and use at system, organisational, and professional levels.
Healthcare professionals - including general practitioners, nurses, specialists and allied health professionals - are encouraged to take part. The survey captures healthcare professional’s experiences with blood-based biomarkers and digital cognitive assessments, including:
Knowledge and skills
Perceived value and usability
Organisational support and adoption in routine care.
The study is led by the London School of Economics and Political Science in collaboration with the Davos Alzheimer’s Collaborative, both partners in AD-RIDDLE. The survey was promoted during the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) held in Copenhagen (17-21 March), where AD-RIDDLE partners distributed flyers to healthcare professionals.
Healthcare professionals interested in contributing can learn more and access the survey here: https://ad-riddle.org/frontline-care-staff-survey/
